IBDEI0SQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13214,0)
 ;;=H40.243^^80^754^113
 ;;^UTILITY(U,$J,358.3,13214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13214,1,3,0)
 ;;=3^Residual Stage Angle-Closure Glaucoma,Bilateral
 ;;^UTILITY(U,$J,358.3,13214,1,4,0)
 ;;=4^H40.243
 ;;^UTILITY(U,$J,358.3,13214,2)
 ;;=^5005845
 ;;^UTILITY(U,$J,358.3,13215,0)
 ;;=H40.043^^80^754^121
 ;;^UTILITY(U,$J,358.3,13215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13215,1,3,0)
 ;;=3^Steroid Responder,Bilateral
 ;;^UTILITY(U,$J,358.3,13215,1,4,0)
 ;;=4^H40.043
 ;;^UTILITY(U,$J,358.3,13215,2)
 ;;=^5005738
 ;;^UTILITY(U,$J,358.3,13216,0)
 ;;=B02.39^^80^755^10
 ;;^UTILITY(U,$J,358.3,13216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13216,1,3,0)
 ;;=3^Herpes Zoster Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,13216,1,4,0)
 ;;=4^B02.39
 ;;^UTILITY(U,$J,358.3,13216,2)
 ;;=^5000498
 ;;^UTILITY(U,$J,358.3,13217,0)
 ;;=B00.59^^80^755^9
 ;;^UTILITY(U,$J,358.3,13217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13217,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,13217,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,13217,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,13218,0)
 ;;=B25.9^^80^755^8
 ;;^UTILITY(U,$J,358.3,13218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13218,1,3,0)
 ;;=3^Cytomegaloviral Disease,Unspec
 ;;^UTILITY(U,$J,358.3,13218,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,13218,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,13219,0)
 ;;=H32.^^80^755^6
 ;;^UTILITY(U,$J,358.3,13219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13219,1,3,0)
 ;;=3^Chorioretinal Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,13219,1,4,0)
 ;;=4^H32.
 ;;^UTILITY(U,$J,358.3,13219,2)
 ;;=^5005489
 ;;^UTILITY(U,$J,358.3,13220,0)
 ;;=B39.9^^80^755^11
 ;;^UTILITY(U,$J,358.3,13220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13220,1,3,0)
 ;;=3^Histoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,13220,1,4,0)
 ;;=4^B39.9
 ;;^UTILITY(U,$J,358.3,13220,2)
 ;;=^5000638
 ;;^UTILITY(U,$J,358.3,13221,0)
 ;;=B83.0^^80^755^25
 ;;^UTILITY(U,$J,358.3,13221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13221,1,3,0)
 ;;=3^Visceral Larva Migrans
 ;;^UTILITY(U,$J,358.3,13221,1,4,0)
 ;;=4^B83.0
 ;;^UTILITY(U,$J,358.3,13221,2)
 ;;=^5000799
 ;;^UTILITY(U,$J,358.3,13222,0)
 ;;=B58.01^^80^755^24
 ;;^UTILITY(U,$J,358.3,13222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13222,1,3,0)
 ;;=3^Toxoplasma Chorioretinitis
 ;;^UTILITY(U,$J,358.3,13222,1,4,0)
 ;;=4^B58.01
 ;;^UTILITY(U,$J,358.3,13222,2)
 ;;=^5000724
 ;;^UTILITY(U,$J,358.3,13223,0)
 ;;=H44.001^^80^755^22
 ;;^UTILITY(U,$J,358.3,13223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13223,1,3,0)
 ;;=3^Purulent Endophthalmitis,Right Eye,Unspec
 ;;^UTILITY(U,$J,358.3,13223,1,4,0)
 ;;=4^H44.001
 ;;^UTILITY(U,$J,358.3,13223,2)
 ;;=^5005963
 ;;^UTILITY(U,$J,358.3,13224,0)
 ;;=H44.002^^80^755^21
 ;;^UTILITY(U,$J,358.3,13224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13224,1,3,0)
 ;;=3^Purulent Endophthalmitis,Left Eye,Unspec
 ;;^UTILITY(U,$J,358.3,13224,1,4,0)
 ;;=4^H44.002
 ;;^UTILITY(U,$J,358.3,13224,2)
 ;;=^5005964
 ;;^UTILITY(U,$J,358.3,13225,0)
 ;;=H44.003^^80^755^20
 ;;^UTILITY(U,$J,358.3,13225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13225,1,3,0)
 ;;=3^Purulent Endophthalmitis,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13225,1,4,0)
 ;;=4^H44.003
 ;;^UTILITY(U,$J,358.3,13225,2)
 ;;=^5005965
 ;;^UTILITY(U,$J,358.3,13226,0)
 ;;=H16.061^^80^755^19
 ;;^UTILITY(U,$J,358.3,13226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13226,1,3,0)
 ;;=3^Mycotic Corneal Ulcer,Right Eye
 ;;^UTILITY(U,$J,358.3,13226,1,4,0)
 ;;=4^H16.061
 ;;^UTILITY(U,$J,358.3,13226,2)
 ;;=^5004890
